
Innovent Biologics Investor Relations Material
Latest events

Corporate Presentation
Innovent Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Innovent Biologics Inc
Access all reports
Innovent Biologics Inc. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of biologic drugs, primarily targeting oncology, autoimmune, metabolic, and ophthalmology diseases. The company develops monoclonal antibodies and other biologic therapies aimed at addressing unmet medical needs, particularly within the Chinese market. The company is headquartered in Suzhou, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for Innovent Biologics Inc


H2 2024
Innovent Biologics Inc


H2 2024
Innovent Biologics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
1801
Country
🇭🇰 Hong Kong